Business · 20/11/20261 min read
Tsingke Highlights How Biotech Teams Can Evaluate and Advance Antibody Candidates at PEGS Europe 2026
Summary
From early antibody hits to engineered formats and antibody–oligonucleotide conjugates, Tsingke helps R&D teams generate the data they need to make the next development decision. LISBON, Portugal, Nov. 20, 2026 — An antibody that binds its target is a starting point for drug...